Trends in Pneumococcal and Bacterial Meningitis in Brazil from 2007 to 2019

Author:

Parellada Cintia Irene1ORCID,Abreu Ariane de Jesus Lopes de2ORCID,Birck Marina G.2,Dias Carolina Zampirolli2,Moreira Thais das Neves Fraga1,Julian Guilherme Silva2,Batista Paula de Mendonça1ORCID,Orengo Juan Carlos3ORCID,Bierrenbach Ana Luiza4ORCID

Affiliation:

1. MSD Brazil, São Paulo 04583-110, Brazil

2. IQVIA Brazil, São Paulo 04719-002, Brazil

3. MSD (IA) LLC, Guaynabo 00966, Puerto Rico

4. Instituto de Ensino e Pesquisa, Hospital Sírio-Libanês, São Paulo 01308-050, Brazil

Abstract

The pneumococcal conjugate vaccination (PCV) was introduced into the Brazilian Childhood National Immunization Program in 2010; however, universal pneumococcal vaccination for older adults has not been implemented yet. Our aim is to evaluate the trends in pneumococcal meningitis incidence and case fatality rate (CFR) across all age groups from 2007 to 2019 using data from the National Surveillance System. The pre-PCV (2007–2009) and post-PCV (2011–2019) periods were compared; changes in incidence and CFR were assessed by joinpoint regression. Additional analyses of bacterial meningitis were performed to compare the patterns and trends. Over the 13-year period, 81,203 and 13,837 cases were classified as bacterial and pneumococcal meningitis, respectively. S. pneumoniae was the main etiological agent of bacterial meningitis in adults aged ≥50 years and the most lethal in all age groups. In the post-PCV period, a 56.5% reduction in the average incidence was seen in pneumococcal meningitis in the pediatric population. In contrast, there was an increasing trend among adults. The CFR for pneumococcal and bacterial meningitis remained stable in most age groups during the study period. These findings highlight the value of expanding pneumococcal vaccination policies, including vaccines that provide better indirect protection from children to adults and broadening vaccination to older adults.

Funder

Merck Sharp & Dohme LLC

Publisher

MDPI AG

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery,Pharmacology,Immunology

Reference47 articles.

1. Epidemiology of community-acquired bacterial meningitis;Brouwer;Curr. Opin. Infect. Dis.,2018

2. Schiess, N., Groce, N.E., and Dua, T. (2021). The Impact and Burden of Neurological Sequelae Following Bacterial Meningitis: A Narrative Review. Microorganisms, 9.

3. World Meningitis Day and the World Health Organization′s roadmap to defeat bacterial meningitis in the COVID-19 pandemic era;Pinto;Int. J. Infect. Dis.,2021

4. GBD 2016 Meningitis Collaborators (2018). Global, regional, and national burden of meningitis, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol., 17, 1061–1082.

5. GBD 2019 Antimicrobial Resistance Collaborators (2022). Global mortality associated with 33 bacterial pathogens in 2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet, 400, 2221–2248.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3